The emerging approach of the medication represents a exciting advance in the care of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects dual pathways – GLP-1 and GIP – leading to improved https://tirzepatidepeptide797674.full-design.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-84656980